Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (431-440 of 509) with videos related to

Pageof 51
Sort By:
Antiviral Therapy|February 19, 2015
Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep LangeT Sonia Boender, Françoise Barré-Sinoussi, David Cooper, et al.
JAMA|July 20, 2010
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panelMelanie A Thompson, Judith A Aberg, Pedro Cahn, et al.
ACS Nano|January 23, 2015
Prospects of nanoscience with nanocrystalsMaksym V Kovalenko, Liberato Manna, Andreu Cabot, et al.
The Journal of Infectious Diseases|October 26, 2017
Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid BiomarkersRosan A van Zoest, Jonathan Underwood, Davide De Francesco, et al.
Antiviral Therapy|February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studiesRoss J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
AIDS (London, England)|November 8, 2017
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?Amanda Mocroft, Kamilla Laut, Peter Reiss, et al.
Journal of the International AIDS Society|March 22, 2021
Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United StatesDavid C Boettiger, Anthony T Newall, Andrew Phillips, et al.
Plos One|March 30, 2018
The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristicsDavide De Francesco, Ferdinand W Wit, James H Cole, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2009
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppressionDavid M Moore, Ross Harris, Viviane Lima, et al.
AIDS (London, England)|October 17, 2022
Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIVErich S Tusch, Lene Ryom, Olga Fursa, et al.
Pageof 51

Showing results (431-440 of 509) with videos related to

Sort By:
Pageof 51
Antiviral Therapy|February 19, 2015
Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep LangeT Sonia Boender, Françoise Barré-Sinoussi, David Cooper, et al.
JAMA|July 20, 2010
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panelMelanie A Thompson, Judith A Aberg, Pedro Cahn, et al.
ACS Nano|January 23, 2015
Prospects of nanoscience with nanocrystalsMaksym V Kovalenko, Liberato Manna, Andreu Cabot, et al.
The Journal of Infectious Diseases|October 26, 2017
Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid BiomarkersRosan A van Zoest, Jonathan Underwood, Davide De Francesco, et al.
Antiviral Therapy|February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studiesRoss J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
AIDS (London, England)|November 8, 2017
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?Amanda Mocroft, Kamilla Laut, Peter Reiss, et al.
Journal of the International AIDS Society|March 22, 2021
Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United StatesDavid C Boettiger, Anthony T Newall, Andrew Phillips, et al.
Plos One|March 30, 2018
The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristicsDavide De Francesco, Ferdinand W Wit, James H Cole, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2009
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppressionDavid M Moore, Ross Harris, Viviane Lima, et al.
AIDS (London, England)|October 17, 2022
Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIVErich S Tusch, Lene Ryom, Olga Fursa, et al.
Pageof 51